Gilead beats, cuts 2026 EPS guidance to $1.05-$0.65 loss
Gilead beats Q1 estimates with non-GAAP EPS $2.03 and revenue $7.0B, cuts 2026 EPS guidance to $1.05-$0.65 loss
- Non-GAAP EPS of $2.03 rose 12% YoY; revenue of $7.0B grew 4% YoY.
- Q1 results beat both EPS and revenue analyst consensus estimates.
- Raised full-year 2026 product sales guidance while reducing both GAAP and non-GAAP EPS outlook to loss.
- Guidance cut reflects $11.5 billion anticipated acquired IPR&D charges and financing costs from recent acquisitions.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.